11th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)

11th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) is organized by Kenes Group and will be held during Feb 14 - 17, 2018 at Austria Center Vienna, Vienna, Wien, Austria.

The target audience for this medical event is international, regional and national specialists in the fields of diabetes, endocrinology, and metabolism, diabetes technology developers as well as pediatricians and family medicine practitioners. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience. ATTD 2018 brings together clinicians, such as diabetologists, endocrinologists as well as pediatricians and family medicine practitioners, scientists, engineers, start-ups, investors, medical corporations, regulators.

Conference Description :
The world of diabetes treatment is evolving at a dynamic pace that requires harmonization with research, technical advances and devices innovations. Over the last 10 years, the annual ATTD meeting has become the premier international forum to present and discuss innovative and comprehensive overview of the latest research developments in this field.

Conference Objectives :
After attending this event, participants should be able to:
• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Discuss the he role of patients in increasing access to new treatments of diabetic patients.
• Review the International Diabetes Closed-Loop (iDCL) Trial.
• Describe automated insulin delivery system algorithms in adolescents and young adults with Type 1 diabetes.
• Discuss the update on worldwide efforts to prevent Type 1 diabetes.
• Identify the latest research outcomes about digital health technology used to prevent and treat diabetes.
• Exchange ideas and knowledge about the effectiveness of insulin pump therapy.
• Discuss the advances of diabetes technology in developing countries.

Additional details will be posted as soon as they are available.